Osteal Therapeutics is a Dallas-based, privately held biotechnology company redefining the standard of care for life-altering orthopedic infections.
Osteal is hiring to launch NEXCHANGE™ KIT, a first-of-its-kind FDA Breakthrough Therapy for periprosthetic joint infection (PJI), a critical condition impacting 50,000 Americans annually. PJI currently lacks FDA-approved therapies and forces patients through grueling, months-long treatments with poor outcomes. Our disruptive technology transforms this journey by safely delivering high-concentration, broad-spectrum antibiotics directly to the infection site; reducing the treatment timeline from months to just seven days.
Powered by $137M in funding to date and a distinguished investor base that includes strategic partners Johnson & Johnson and Zimmer Biomet, we are advancing toward FDA approval and building the organization that will bring this therapy to patients in dire need.
We are looking for bold, relentless professionals who thrive in a “builder” environment. If you are driven by the opportunity to do work that genuinely matters — to be part of a cohesive and capable team striving to deliver the first on-label PJI treatment that promises to transform outcomes for tens of thousands of patients.
The Account Manager is a hospital-based sales role responsible for driving demand, influencing adoption, and owning territory results within an assigned geography during Osteal’s inaugural product launch. This role advances adoption by securing hospital access through strong clinical advocacy, educating and training key stakeholders, and turning early clinical experience into sustained use.
The Account Manager serves as a trusted advisor to orthopedic surgeons, infectious disease specialists, and hospital stakeholders, leveraging clinical credibility, consultative engagement, and launch experience to influence clinical decision-making and grow the business. Success in this role requires an experienced hospital sales professional with a demonstrated ability to execute in complex hospital environments, launch new products, build territories from the ground up, and consistently deliver results across surgical and infectious disease settings.
Osteal Therapeutics is a privately-held, clinical-stage pharmaceutical company developing novel musculoskeletal therapeutics to treat orthopedic infections and their consequences.
